Short-Term Picks: DMART, MCX, AUROPHARMA Recommended by Experts
Analyzing: “Stocks to buy for short term: From DMart, MCX to Aurobindo Pharma— Experts suggest 6 stock picks for next 1-2 weeks” by livemint_markets · 31 Mar 2026, 10:15 AM IST (about 1 month ago)
What happened
Market experts Vishnu Kant Upadhyay and Hitesh Tailor had recommended six specific Indian stocks, including Avenue Supermarts (DMart), MCX, and Aurobindo Pharma, for short-term trading over a 1-2 week horizon. This indicates a positive outlook on these scrips from a technical or fundamental perspective at the time of recommendation.
Why it matters
While the recommendations are a month old, they highlight specific stocks that analysts believed had short-term upside potential. For traders, such expert calls can serve as a starting point for their own analysis, especially if the underlying reasons for the recommendation (e.g., technical breakouts, sector tailwinds) are still valid.
Impact on Indian markets
The direct impact on DMART, MCX, and AUROPHARMA would have been a potential increase in buying interest following the recommendations. For the broader market, such calls can sometimes indicate a general bullish sentiment towards specific sectors or themes that these stocks represent, such as retail, commodities, or pharmaceuticals.
What traders should watch next
Traders should now analyze the current price action, volume, and any recent news for DMART, MCX, and AUROPHARMA. Look for confirmation of the original bullish thesis, such as continued upward momentum, strong support levels, or positive fundamental developments since the recommendation was made. Also, assess the broader market sentiment and sector performance.
Key Evidence
- •Vishnu Kant Upadhyay of Master Capital Services recommended stocks.
- •Hitesh Tailor of Choice Broking recommended stocks.
- •Six stocks were recommended for the next 1-2 weeks.
- •Avenue Supermarts (DMart), MCX, and Aurobindo Pharma were among the recommended stocks.
Affected Stocks
Recommended as a short-term buy by experts.
Recommended as a short-term buy by experts.
Recommended as a short-term buy by experts.
People in this Story
Sources and updates
AI-powered analysis by
Anadi Algo News